Clinical Trial Update: Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults [Phase 4]

View source ↗

Summary

Phase 4 trial reporting immunogenicity and safety of a booster dose of Boostrix Polio vaccine in adults previously boosted, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Boostrix Polio vaccine (Diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acellular Pertussis, Poliomyelitis | Phase 4 | Status: COMPLETED | Results posted: 2017-08-03